Genomic biomarkers in metastatic colorectal cancer
John Strickler, MD Duke Cancer Center, Durham, NC Kristen Ciombor, MD, MSCI Vanderbilt-Ingram Cancer Center, Nashville, TN Yoshiaki Nakamura, MD, PhD, National Cancer Center Hospital East, Kashiwa, Japan Benedikt Westphalen, MD LMU Hospital, Munich, Germany Sebastian Stintzing, MD Charite University Hospital, Berlin, Germany Filippo Pietrantonio, MD Istituto Nazionale dei Tumori, Milan, Italy Several genetic alterations play a role in the pathogenesis of mCRC, and testing of these biomarkers is an